Skip to main content
. 2014 Sep;12(5):402–407. doi: 10.1370/afm.1683

Table 1.

Characteristics of Study Cohort

Characteristic Income Quintilea
Q1 (Lowest)
(n = 7,915)
Q2
(n = 7,362)
Q3
(n = 6,685)
Q4
(n = 6,679)
Q5 (Highest)
(n = 6,100)
Hospitalized, % 3.6 2.5 1.7 1.3 1.0
Patient demographics
 Sex, male, % 39.1 41.5 42.4 44.4 44.5
 Age, mean (SD), y 46.6 (14.6) 46.4 (14.5) 47.2 (14.5) 47.0 (14.3) 46.7 (14.4)
Comorbidity level (major ADGs)b
 Low (0–1), % 57.3 67.5 69.8 71.7 74.3
 Medium (2–3), % 35.2 28.0 26.7 25.0 23.3
 High (≥4), % 7.5 4.5 3.5 3.3 2.4
Ambulatory care usec
 Physician visits, mean No. (SD) 29.1 (23.1) 22.6 (18.6) 22.1 (18.3) 20.8 (17.1) 20.0 (16.5)
 Usual physician index, mean (SD)d 0.59 (0.23) 0.63 (0.23) 0.64 (0.22) 0.64 (0.22) 0.62 (0.22)
 Received influenza vaccine, % 33.9 31.3 32.4 32.6 32.6
 Referred to specialist, % 7.3 6.6 7.1 5.9 7.1
Usual physician characteristicse
 Type, family physician, % 91.6 92.3 91.7 91.8 90.7
 Payment, fee for service, % 96.6 97.1 97.6 97.8 97.7
 Sex, male, % 80.9 74.3 73.7 72.3 70.3
Time practicing in Manitoba
 1–9 y 27.9 24.4 21.5 21.8 21.9
 10–17 y 27.9 24.5 26.3 24.8 22.7
 ≥18 y 44.2 51.1 52.2 53.5 55.4
Training, international, % 41.0 39.0 38.0 36.5 35.2
Daily patient load, mean No. (SD) 34.8 (16.0) 33.9 (14.3) 33.7 (14.0) 33.0 (13.3) 32.0 (12.7)

ADG = aggregated diagnosis group.

Note: Data only available starting in 1991.

a

All differences between groups were significant at P <.05 on analysis of variance or χ2 analysis.

b

Of 8 major ADGs during 3 years: ADG3, ADG4, ADG9, ADG11, ADG16, ADG22, ADG25, or ADG32.

c

For the 3-year period before index hospitalization or median time to that event; 1-year period for influenza vaccine.

d

Possible range: 0 to 1.0. Higher values indicate greater continuity of care.

e

At the patient level; for example, 80.9% of patients in Q1 had a male usual physician.